Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study

Authors

Keywords

Journal

Volume 82, Issue 7, Pages 573-581

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2014-01-23

DOI

10.1212/wnl.0000000000000125

Discuss science. Find collaborators. Network.

Join a conversation

Explore over 38,000 international journals covering a vast array of academic fields.